Kura Oncology, Inc. financial data

Symbol
KURA on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 05 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 624% % -49%
Debt-to-equity 159% % 476%
Return On Equity -103% % -167%
Return On Assets -40% % -31%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 88,329,759 shares 2%
Common Stock, Shares, Outstanding 87,855,000 shares 12%
Entity Public Float $496,100,000 USD -69%
Common Stock, Value, Issued $9,000 USD 12%
Weighted Average Number of Shares Outstanding, Basic 87,676,000 shares 1.8%
Weighted Average Number of Shares Outstanding, Diluted 87,676,000 shares 1.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $67,482,000 USD
Research and Development Expense $251,074,000 USD 48%
General and Administrative Expense $104,914,000 USD 56%
Nonoperating Income (Expense) $25,262,000 USD 19%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $278,369,000 USD -62%
Income Tax Expense (Benefit) $226,000 USD
Net Income (Loss) Attributable to Parent $278,666,000 USD -60%
Earnings Per Share, Basic -3.18 USD/shares -57%
Earnings Per Share, Diluted -3.18 USD/shares -57%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $149,099,000 USD -34%
Accounts Receivable, after Allowance for Credit Loss, Current $8,804,000 USD 327%
Inventory, Net $413,000 USD
Assets, Current $708,663,000 USD -4.9%
Property, Plant and Equipment, Net $7,855,000 USD 367%
Operating Lease, Right-of-Use Asset $7,302,000 USD 26%
Other Assets, Noncurrent $14,543,000 USD 85%
Assets $738,363,000 USD -2.9%
Accounts Payable, Current $5,017,000 USD 242%
Employee-related Liabilities, Current $22,372,000 USD 28%
Contract with Customer, Liability, Current $48,983,000 USD 102%
Liabilities, Current $116,974,000 USD 49%
Contract with Customer, Liability, Noncurrent $424,909,000 USD 67%
Operating Lease, Liability, Noncurrent $9,469,000 USD 82%
Other Liabilities, Noncurrent $3,165,000 USD 76%
Liabilities $564,228,000 USD 63%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,024,000 USD 34%
Retained Earnings (Accumulated Deficit) $1,174,088,000 USD -31%
Stockholders' Equity Attributable to Parent $174,135,000 USD -58%
Liabilities and Equity $738,363,000 USD -2.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $71,927,000 USD -47%
Net Cash Provided by (Used in) Financing Activities $143,000 USD
Net Cash Provided by (Used in) Investing Activities $101,409,000 USD -6.4%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 87,855,000 shares 12%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $173,193,000 USD -4235%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $149,099,000 USD -34%
Deferred Tax Assets, Valuation Allowance $363,890,000 USD 30%
Deferred Tax Assets, Gross $367,638,000 USD 31%
Operating Lease, Liability $10,746,000 USD 52%
Depreciation $241,000 USD 3%
Payments to Acquire Property, Plant, and Equipment $292,000 USD 248%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $278,406,000 USD -62%
Lessee, Operating Lease, Liability, to be Paid $23,967,000 USD 144%
Property, Plant and Equipment, Gross $10,755,000 USD 117%
Operating Lease, Liability, Current $1,277,000 USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,658,000 USD 172%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,533,000 USD -22%
Operating Lease, Weighted Average Discount Rate, Percent 0.123 pure 7.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8,368,000 USD 205%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,755,000 USD 174%
Deferred Tax Assets, Operating Loss Carryforwards $111,461,000 USD 14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $25,721,000 USD 67%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,853,000 USD 176%
Operating Lease, Payments $900,000 USD -40%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $10,965,000 USD 32%
Interest Expense $1,602,000 USD 4.9%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%